title: [Pharmacological profiles and clinical roles of 5-azacitidine (Vidaza(®) for injection 100 mg) for the treatment of myelodysplastic syndrome (MDS)].
authors.forename: Yukari
authors.initials: Y
authors.lastname: Takahashi
authors.forename: Sachie
authors.initials: S
authors.lastname: Kimura
authors.forename: Masahiko
authors.initials: M
authors.lastname: Okano
mesh_terms: D000818:Animals; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use*; D001374:Azacitidine / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use*; D049109:Cell Proliferation / Q000187:drug effects; D019175:DNA Methylation / Q000187:drug effects; D006801:Humans; D066298:In Vitro Techniques; D009190:Myelodysplastic Syndromes / Q000188:drug therapy*
chemical_list: D000964:Antimetabolites, Antineoplastic; D001374:Azacitidine